Mateen currently works as an Associate Content Writer covering news on healthcaremotives.com and several other news portals. An electronics and telecommunication engineer by profession, he boasts of a professional stint in the electronics industry, post which he switched his career to writing. His other areas of interest include martial arts, swimming and gaming. He can be contacted at- [email protected] | https://twitter.com/MateenDalal
In a recent turn of events, Finland based food group Raisio has joined forces with Italian health & well-being firm Dr. Schär by entering into a strategic alliance for manufacturing and product development. Helsinki-listed food group Raisio cited in a statement that the long-standing framework agreement would open up novel …
Bayer files prostate cancer drug darolutamide with Japanese regulators Bayer hopes to sway drug prescribers and for darolutamide to surpass the billion-euro annual sales milestone on approval. Bayer, the German multinational pharmaceutical company recently announced that it has filed darolutamide, its prostate cancer drug, with the Japanese regulators. It is …
Merck & Co. has recently announced that it has agreed to acquire Immune Design in a deal valued at approx. $300 million, for boosting Merck’s vaccine pipeline and technology capabilities. Apparently, Immune Design had reduced its workforce by 18% last year and established a new lead candidate, after its previous …
ARS-1 can be used for rapid delivery of epinephrine with less hesitation during an allergic reaction when compared to the administration of epinephrine auto-injectors ARS Pharmaceuticals, Inc., the pharmaceutical company known for its contribution to the development of medicines that can prevent severe allergic reactions causing anaphylaxis, recently announced that …
The EM-100 developed by Eton Pharmaceuticals would be the first ever preservative-free eye drop available in U.S. that can be used in allergic ocular itching. Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc, along with its parent company and Eton …
The study was aimed at developing and internally validating the PRODIGY score, which is an accurate OIRD risk assessment scoring tool. Medtronic plc, one of the largest medical technology, services and solutions companies in the world has recently announced that PRODIGY, a study to monitor people at risk of opioid-induced …
panCELLa welcomed Cartherics as a capable partner in the addressing of needs of cancer patients treated with immunotherapy. Cartherics Pty Ltd, the pluripotent stem cell technology developing Australian company and the Canada based panCELLa Inc, an early-stage biotechnology company, recently announced that they will be collaborating on the research and …
SQZ Biotechnologies, a cell therapy conglomerate renowned for developing novel treatments for a wide range of diseases, has recently announced the expansion of its collaboration with Roche in cellular therapy. As per trusted sources, the expanded partnership with Roche’s cancer immunotherapy expertise would further SQZ’s innovation synergistic combination as well …
Los Angeles-based cannabis firm, MedMen Enterprises Inc. has recently announced its binding letter of intent to acquire the Illinois-based medical cannabis provider PharmaCann LLC for a valuation of USD 682 million. With thus takeover, MedMen will be expanding its reach with 79 licensed cannabis facilities amid growing operations in 12 …
U.S. retail drugstore chain, CVS Health Corp. has recently won approval of a $69 billion acquisition of healthcare insurer Aetna, Inc. by the U.S. Department of Justice (DOJ), paving the way for a merger that can cut health care costs for consumers. Sources close to the matter suggest merger of …
